Core Viewpoint - The A-share market is experiencing a strong upward trend, with the medical industry showing significant gains, driven by policy improvements and corporate profit recovery [1] Group 1: Market Trends - The A-share market has recently broken through the 3700-point barrier, indicating a bullish trend [1] - The medical sector is highlighted as a strong performer within the market [1] Group 2: Investment Opportunities - Jianxin Fund is launching the Jianxin Medical Innovation fund, focusing on innovative investment opportunities in the medical field [1][2] - The fund manager emphasizes that China's pharmaceutical innovation capabilities have gained significant global competitiveness, transitioning from imitation to original innovation [1][2] - The number of international authorizations for Chinese innovative drugs is on the rise, reflecting global recognition [1] Group 3: Policy Support - Recent measures from the National Healthcare Security Administration and the National Health Commission support the high-quality development of innovative drugs [1] - Ongoing optimization of the selection rules for national medical insurance procurement is expected to further bolster the innovative drug industry [1] Group 4: Fund Strategy - The Jianxin Medical Innovation fund will focus on a dual market strategy (A+H), with an equity allocation of 80%-95% [2] - The fund will prioritize innovative drugs with broad market potential and clear competitive landscapes, while also considering external authorization probabilities and amounts [2] - A new floating fee structure is introduced to align the interests of investors and fund managers, with management fees varying based on holding period and annualized returns [2]

Core Viewpoint - The rapid acceptance of floating fee rate funds in the market is highlighted by the early closure of fundraising for the China Europe Core Smart Mixed Fund and the E Fund Value Return Mixed Fund, indicating a shift in investor preferences towards performance-linked fee structures [1][2][4] Group 1: Fundraising and Market Response - The China Europe Core Smart Mixed Fund raised over 2 billion yuan and ended its fundraising early, becoming the first in the second batch of floating fee rate funds to exceed this threshold [2] - The E Fund Value Return Mixed Fund also announced an early closure of its fundraising period, reflecting a strong market response to these new fund types [2][3] - The second batch of floating fee rate funds has entered a competitive phase earlier than expected, with 12 new products approved and launched [3] Group 2: Fee Structure Reform - The China Securities Regulatory Commission (CSRC) has initiated a reform of public fund fee structures, promoting floating fee mechanisms that link management fees to fund performance [4][5] - The new fee structure aims to align the interests of fund managers and investors, encouraging better risk management and performance [5][6] - The CSRC's action plan emphasizes investor interests and aims for at least 60% of new active equity fund products to adopt floating fee structures within a year [4] Group 3: Advantages of Floating Fee Rate Funds - Floating fee rate funds are designed to enhance the alignment of interests between fund managers and investors, promoting a shared risk and reward model [5][6] - The new fee mechanism allows for differentiated fee structures based on holding periods, encouraging long-term investment while managing liquidity [6] - The performance evaluation system is closely tied to benchmarks, aiming to minimize style drift and enhance active management capabilities [6]

Core Insights - The early closure of the fundraising for the China Europe Core Select Mixed Fund and the E Fund Value Return Mixed Fund indicates a strong market acceptance of floating fee rate funds, with the former surpassing 2 billion yuan in fundraising [1][2] - The floating fee rate mechanism links management fees directly to investor returns, promoting a shared interest model that enhances fund managers' accountability and long-term investment motivation [1][6] Fundraising Developments - The China Europe Core Select Mixed Fund ended its fundraising early on August 12, having reached a scale of over 2 billion yuan, while the E Fund Value Return Mixed Fund also announced an early closure on August 13 [2] - Both funds are part of the second batch of new floating fee rate funds, which were launched on August 4, and their early closure reflects a competitive environment among these products [2][3] Regulatory Context - The China Securities Regulatory Commission (CSRC) initiated a public fund fee reform in May 2023, introducing a floating management fee mechanism linked to fund performance [4] - The second batch of 12 new floating fee rate funds received approval on July 24, indicating a significant shift in the public fund industry towards performance-based fee structures [4] Advantages of Floating Fee Rate Funds - The new floating fee rate model aligns the interests of fund managers and investors more closely, encouraging fund managers to enhance their active management capabilities while also focusing on risk management [6][7] - This model promotes a "risk sharing, benefit sharing" principle, shifting the focus from mere scale expansion to investment returns, thereby fostering a healthier interaction between fund managers and investors [6][7]

Core Insights - The first floating fee product exceeding 2.1 billion yuan has completed its fundraising ahead of schedule, indicating strong investor interest in this new fee structure [1][2][4] Fundraising Details - The China Europe Core Select Mixed Fund announced an early closure of its fundraising on August 12, with a total raised amount exceeding 2.1 billion yuan [2][4] - The fundraising deadline was moved from August 15 to August 12, and no further subscriptions will be accepted from August 13 [2] - Banks remain the dominant sales channel, with Industrial Bank contributing significantly to the sales volume [2] Market Context - The early closure and high fundraising amount reflect investor confidence in the "performance-linked fee" model, coinciding with a recovery in the equity market and increased risk appetite [4] - The first batch of floating fee funds has shown positive performance, with nearly all funds reporting gains since inception, further encouraging investor participation [6][7] Fund Management - The China Europe Core Select Fund employs a dual fund manager system, with Zhang Cong and Song Ting as the proposed managers, both having significant experience in the investment sector [4] - The fee structure for these funds includes three tiers based on performance relative to benchmarks, incentivizing managers to achieve higher returns [5] Performance Metrics - As of August 11, the first batch of 26 floating fee funds has mostly achieved positive returns, with the highest return being 10.23% for the fund established on June 27 [6] - The performance benchmarks for these funds vary, with specific indices set for comparison, such as the CSI 800 Index and the Hang Seng Medical Care Index [5] Industry Trends - The floating fee fund model is expanding into various sectors, including healthcare and manufacturing, indicating a broader acceptance and potential for growth in this fund type [7] - The success of the initial floating fee funds may lead to increased participation from other fund companies, creating a ripple effect in the market [7]